Financial

CeloNova Announces Appointment of New President and CEO

SAN ANTONIO, Texas, Aug. 6, 2019 /PRNewswire/ — CeloNova BioSciences, Inc. (CeloNova), a global medical device company and manufacturer of the proprietary Polyzene™-F nanocoating technology, currently used to surface coat its novel COBRA PzF NanoCoated Coronary Stent (NCS), today announced appointment of seasoned medical device executive Carl J. St. Bernard as President and Chief Executive Officer […]

Quanterix Corporation Releases Operating Results for Second Quarter 2019

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the three and six months ended June 30, 2019. “We are pleased with our execution and yet another quarter of record results, with strong revenue growth and […]

BioCardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq

SAN CARLOS, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) — BioCardia, Inc. (NasdaqCM: BCDA, BCDAW), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the pricing of its public offering of 1,666,667 units at a price to the public of $6.00 per unit. Each unit issued in the […]

Avinger Reports 26% Sequential Revenue Growth in Second Quarter 2019

Revenue Growth Fuels Strong Operating Metrics Pantheris SV Limited Launch at Key U.S. Sites in July REDWOOD CITY, Calif., July 31, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with […]

Leviticus Cardio Appoints Prof. Nir Uriel to its Scientific Advisory Board

PETAH-TIKVA, Israel, Aug. 1, 2019 /PRNewswire/ — Leviticus Cardio today announced the appointment of Prof. Nir Urielto its Scientific Advisory Board. “We are very excited that Prof. Uriel has joined our Scientific Advisory Board. He is a leader in the field of heart failure, mechanical circulatory support and heart transplantation, and he will help us greatly in promoting our […]

Abiomed Announces Q1 FY 2020 Revenue of $208 Million and 29.2% Operating Margin

DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported first quarter fiscal 2020 revenue of $207.7 million, an increase of 15.4% compared to revenue of $180.0 million for the same period of fiscal 2019. Operating income was $60.7 million, up 30%, compared […]